![Kristine Ball](data:image/svg+xml,<svg xmlns="http://www.w3.org/2000/svg" width="16" height="16" fill="%231b1b1b" class="bi bi-person-fill" viewBox="0 0 16 16"><path d="M3 14s-1 0-1-1 1-4 6-4 6 3 6 4-1 1-1 1zm5-6a3 3 0 1 0 0-6 3 3 0 0 0 0 6"/></svg>)
Kristine Ball
Chief Executive Officer at
Antiva Biosciences, Inc.
Net worth: - $ as of 2026-06-29
Profile
Kristine McClintock Ball is President & Chief Executive Officer at Antiva Biosciences, Inc. since 2023.
Director at National Kidney Foundation of Northern California.
Independent Director at Oruka Therapeutics, Inc. starting 2024.
Former Chief Executive Officer & Director at Soteria Biotherapeutics, Inc. from 2020 to 2022.
Independent Director at Forty Seven LLC from 2018 to 2020.
Independent Director at Atreca, Inc. from 2020 to 2024.
Senior Manager at Ernst & Young LLP from 1998 to 2000.
Vice President-Finance at Exelixis, Inc. from 2000 to 2005.
Chief Financial Officer & SVP-Corporate Strategy at Menlo Therapeutics, Inc. from 2017 to 2020.
Chief Financial Officer & Senior Vice President at Relypsa, Inc. from 2012 to 2016.
CFO, Senior VP-Administration & Finance at KAI Pharmaceuticals, Inc. from 2005 to 2012.
Completed undergraduate education at Babson College.
Known holdings in public companies
| Company | Date | Number of shares | Valuation | Valuation date |
|---|---|---|---|---|
-.--% | 2026-06-01 | 0 ( -.--% ) | - $ | 2026-06-29 |
Kristine Ball active positions
| Companies | Position | Start |
|---|---|---|
National Kidney Foundation of Northern California
 National Kidney Foundation of Northern California The National Kidney Foundation of Northern California is a company based in San Francisco, CA. | Director/Board Member | - |
Antiva Biosciences, Inc.
 Antiva Biosciences, Inc. BiotechnologyHealth Technology Provides antiviral therapeutics | Chief Executive Officer | 2023-04-26 |
Former positions of Kristine Ball
| Companies | Position | End |
|---|---|---|
| ATRECA, INC. | Director/Board Member | 2023-12-31 |
Soteria Biotherapeutics, Inc.
 Soteria Biotherapeutics, Inc. BiotechnologyHealth Technology Develops T-cell engagers to treat patients with solid tumor cancers | Chief Executive Officer | 2022-07-31 |
| FORTY SEVEN, INC. | Director/Board Member | 2020-04-06 |
| VYNE THERAPEUTICS | Director of Finance/CFO | 2020-02-29 |
| RELYPSA INC | Director of Finance/CFO | 2016-09-30 |
Training of Kristine Ball
Experiences
Positions held
Active
Inactive
Listed companies
Private companies
Connections
60
1st degree connections
11
1st degree companies
Male
Female
Members of the board
Executives
Linked companies
| Private companies | 11 |
|---|---|
Ernst & Young LLP
 Ernst & Young LLP Miscellaneous Commercial ServicesCommercial Services Provides assurance, auditing, tax, legal, technology and consulting & managed services | Commercial Services |
Exelixis, Inc.
 Exelixis, Inc. Pharmaceuticals: MajorHealth Technology Operates as a cancer drug discovery company | Health Technology |
KAI Pharmaceuticals, Inc.
 KAI Pharmaceuticals, Inc. Pharmaceuticals: MajorHealth Technology Discovers and develops biopharmaceutical drugs | Health Technology |
Atreca, Inc.
 Atreca, Inc. Pharmaceuticals: MajorHealth Technology Operates as a biopharmaceutical company that develops novel antibody-based immune therapeutics to treat a range of solid tumor cancers | Health Technology |
Menlo Therapeutics, Inc.
 Menlo Therapeutics, Inc. Pharmaceuticals: MajorHealth Technology Engages in development and commercialization of serlopitant products | Health Technology |
Antiva Biosciences, Inc.
Antiva Biosciences, Inc. BiotechnologyHealth Technology Provides antiviral therapeutics | Health Technology |
Babson College
 Babson College Other Consumer ServicesConsumer Services Functions as a College/University | Consumer Services |
Relypsa, Inc.
 Relypsa, Inc. Pharmaceuticals: MajorHealth Technology Discovers and develops non-absorbed polymeric drugs for applications in cardiovascular and renal diseases | Health Technology |
Forty Seven, Inc.
 Forty Seven, Inc. Pharmaceuticals: MajorHealth Technology Develops therapies for cancer treatment | Health Technology |
National Kidney Foundation of Northern California
National Kidney Foundation of Northern California The National Kidney Foundation of Northern California is a company based in San Francisco, CA. | |
Soteria Biotherapeutics, Inc.
Soteria Biotherapeutics, Inc. BiotechnologyHealth Technology Develops T-cell engagers to treat patients with solid tumor cancers | Health Technology |
- Stock Market
- Insiders
- Kristine Ball
